Item 8.01 Other Events. On April 20, 2020, Ge
Post# of 36537
On April 20, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from Tufts Medical Center regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
Tufts Medical Center is an internationally-respected academic medical center – a teaching hospital where it prides itself not only in the sophistication of the care it provides but the compassionate way in which Tufts Medical Center provides it. Tufts Medical Center cares for all patients from the tiniest newborns at its full-service pediatric hospital, Floating Hospital for Children, to centenarians in its specialized Geriatrics clinic. Tufts Medical Center is the principal teaching hospital for Tufts University School of Medicine. Tufts Medical Center conducts groundbreaking medical and health policy research and is in the top 10 percent of independent institutions receiving federal research funding.